+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

The Worldwide Market for In Vitro Diagnostic Tests, 15th Edition

  • Report
  • 1583 Pages
  • September 2022
  • Region: Global
  • Kalorama Information
  • ID: 5412038

COVID-19 Impact & Summary, Regions of Market Influence, and What to Watch For Long-Term

In Vitro Diagnostics (IVD) is an enormous market and having comprehensive information on the state of IVD and its future is a vital part of making well-informed decisions. The 15th edition of The Worldwide Market for In Vitro Diagnostic Tests provides readers with reliable estimates, real-world forecasts, and insights needed to understand the IVD market in its entirety. This 1,500+ page report is based on vendor reporting, interviews, vendor activities, and more on a global scale. The full assessment of the IVD diagnostic market makes The Worldwide Market for In Vitro Diagnostic Tests the most trusted report by top companies in the industry.

The Most Comprehensive Market Research in IVD, Now in its 15th Edition

The report has complete IVD market research sections with test segment estimates and forecasts in: Clinical Chemistry, Hematology, Histology, Company Profiles and Rankings, Molecular, Immunoassay, Infectious Disease, Coagulation, Blood Bank IVD, Point of Care. This is every significant segment in in vitro diagnostics.

Every significant test category in IVD is given a chapter with sub-segments. It’s like having ten market research reports in one.

The Worldwide Market for In Vitro Diagnostic Tests is the result of months of analysis and review of secondary sources by seasoned analysts, critical readings of current and historic company filings and releases, interviews with relevant experts and searching of government sources and journal literature. All test segments contain valuable information on current market size and future projection. Compound annual growth rate is provided, as well as significant IVD companies in the market and IVD manufacturer’s product innovations. This detailed look at the IVD market yields unparalleled global market modeling.

Why The Worldwide Market for In Vitro Diagnostic Tests?

  • Maximum Value: One Report, All Segments, World Markets
  • Published Since 1999, by an Expert Firm That Focuses on IVD and Related Healthcare 
  • Profiles of 300+ Companies in the Market, Detail on the Top 40
  • Use the Industry-Utilized and Business Planning Numbers
  • Learn Who is Launching Products and Investing in the IVD Industry
  • Overall IVD Markets for Every Significant Nation, Detail for Major Markets
  • Based on Latest Financial Reporting, Real-World Industry and Medical Practice Trends

This report gives you definitive answers to important questions like:

  • What is the Size of IVD Market Segments?
  • Within Those Segments, How Do They Break Down?
  • Where Will Those Markets be In Five Years?
  • How Has the IVD Market Changed Over Time?
  • Who’s Winning?
  • Who’s Merged?
  • Who’s Launched Game-Changing Products?
  • What is the Competitive Landscape?
  • Who Can I Partner With?
  • Where are the Growth Markets I Can Enter or Buy Into?
  • and more...

The most essential report on the IVD industry, The Worldwide Market for In Vitro Diagnostic Tests is a must-have tool for understanding the IVD market on a deeper level.

Country-Level Coverage

The in vitro diagnostics market is a global one, and The Worldwide Market for In Vitro Diagnostic (IVD) Tests reflects the international scope of the in vitro diagnostics market size. In the healthcare market, IVD companies sell globally and think globally.

Overall IVD market size for every significant world country. Detail for major market segments, US, Japan, Europe, China.

Trends in one part of the world affect IVD manufacturers’ product decisions and company financial performance in others.

Thus, this is a global report, and the following regional and country overall IVD markets are included:

  • US
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Netherlands
  • Turkey
  • Poland
  • Canada
  • China
  • Japan
  • Malaysia
  • Singapore
  • South Korea
  • Australia
  • Saudi Arabia
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • South Africa
  • Eastern Europe
  • Emerging Markets
  • Rest of World

The Worldwide Market for In Vitro Diagnostic Tests is a testament to the analyst's methodology. It is the result of months of painstaking work by an experienced IVD industry analyst, who has tracked hundreds of in vitro diagnostic companies for developments, trends and financial results. This research is compiled along with the opinion, observations and insights of industry experts to produce an unparalleled vision of the in vitro diagnostics industry as it is in 2022.

Competitive Analysis and Corporate Profiling

The report concentrates over a thousand pages on detailed and tiered profiles of companies in the in vitro diagnostics market. The experience that the analyst has in the in vitro diagnostic market is evident in its tiering and segmentation of companies.

Profiles of IVD-relevant companies. No other resource comes close.

First tier, second-tier and specialist companies are profiled. Financial results, product launches, company history and strategic plans are analyzed in the profiles. Over 200 Profiles are included in the report.

Companies profiled include these, and many others:

  • Abbott Diagnostics
  • Accelerate Diagnostics, Inc.
  • Altona Diagnostics
  • Amoy Diagnostics Co. Ltd.
  • Angle
  • Arkray
  • ARUP Laboratories
  • Ascensia Diabetes Care Holdings AG
  • Beckman Coulter
  • Becton Dickinson (BD)
  • BGI Genomics (formerly Beijing Genome Institute)
  • Binding Site Group Ltd. (The)
  • Biocartis
  • Biocept, Inc.
  • Biohit
  • Biomerica Inc.
  • bioMerieux
  • Bio-Rad
  • BioReference Laboratories
  • Bio-Techne Corporation
  • Biotheranostics
  • Bruker
  • CareDx, Inc.
  • CellaVision AB
  • Cepheid
  • Cepheid / Danaher
  • Cerner Corp.
  • Copan
  • Corgenix Medical Corporation
  • Critical Diagnostics
  • Curetis
  • Cynvenio Biosystems (LungLife AI)
  • Dako A/S
  • Danaher
  • Dexcom Inc.
  • Diagnostica Stago, S.A.S.
  • DIAGON Kft. Hungary
  • DiaSorin
  • Edico Genome (Illumina)
  • Eiken Chemical Co. Ltd.
  • EKF Diagnostics Holdings PLC
  • ELITech Group S.A.S.
  • Epic Sciences
  • Epigenomics AG
  • ERBA Diagnostics, Inc.
  • Fujirebio
  • Fujirebio Diagnostics, Inc.
  • Genomic Health (Exact Sciences)
  • Greiner Bio-One International GmbH
  • Grifols
  • Guardant Health, Inc.
  • Hain Lifescience GmbH
  • Hologic
  • Horiba Medical
  • HTG Molecular Diagnostics
  • Human Longevity Inc.
  • Illumina
  • Immucor
  • Immunodiagnostic Systems (IDS)
  • INOVA Diagnostics, Inc.
  • Instrumentation Laboratory
  • Lab Corp
  • Leica Biosystems
  • LifeScan Inc.
  • Luminex Corporation
  • Medica Corporation
  • MedTest DX
  • Menarini Diagnostics
  • Meridian Bioscience, Inc.
  • MilliporeSigma
  • Mindray
  • Nova Biomedical
  • Perkin Elmer
  • PerkinElmer, Inc. (PE)
  • Qiagen
  • Quest
  • Quest Diagnostics
  • Quidel Ortho
  • Radiometer
  • Randox
  • Randox Laboratories Ltd.
  • Rennova Health, Inc.
  • Response Biomedical Corp.
  • Roche Diagnostics
  • SD Biosensor
  • Seegene
  • Sekisui Diagnostics LLC
  • Shimadzu Scientific Instruments
  • Siemens Healthineers
  • Singulex, Inc.
  • Snibe Co. Ltd.
  • Sonic Healthcare
  • Sysmex
  • Tecan Group
  • Thermo Fisher Scientific
  • Tosoh Bioscience
  • Trinity Biotech PLC
  • Werfen

Table of Contents

Chapter One: Executive Summary
  • Scope and Methodology
  • Size and Growth of the Market
  • IVD Market Highlights
  • Point of View
  • Significant Gains in IVD Segments Over Three Years
  • COVID-19 Impact and Summary
  • What to Watch Long-Term
  • Regions of Market Influence: Korea and China
  • Collaborations Between IVDs
  • New Sample Methods
  • PAMA on the Horizon, Particularly for POC
  • African Nations IVD Market
Chapter Two: Introduction
  • IVD Landscape
  • Report Design
  • Changes Between 14th and 15th Editions
  • PAMA and CMS
  • Market Analysis of IVD Market Segments
  • Top Suppliers and Niche Players
  • Introduction
  • Overview of the Top Tier Companies
  • Abbott Diagnostics
  • Roche Diagnostics
  • *Ventana Medical Systems/ Roche Tissue Diagnostics
  • Danaher Corporation
  • *Cepheid
  • *Radiometer
  • *Beckman Coulter
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Illumina
  • Becton Dickinson & Co
  • bioMérieux
  • Sysmex Corporation
  • Dexcom
  • Hologic
  • Quidel Corporation
  • Werfen
  • *Instrumentation Laboratory
  • *Inova Diagnostics
  • Exact Sciences
  • Ortho Clinical Diagnostics
  • PerkinElmer
  • DiaSorin Group
  • Bio-Rad Laboratories
  • Agilent
  • QIAGEN N.V.
  • Overview of Selected Second Tier Companies
  • Mindray
  • BGI Genomics
  • Bruker/CALID Group
  • Natera
  • Fulgent Genetics
  • Myriad Genetics
  • Fujirebio
  • Grifols S.A.
  • Invitae
  • Diagnostica Stago
  • Cue Health
  • Guardant Health
  • Eiken Chemical Co
  • Nihon Kohden
  • Horiba/ABX
  • Luminex Corporation
  • OraSure Technologies
  • Menarini Diagnostics
  • Meridian
  • Masimo
  • The Impact of COVID for the Top Tier Companies
  • IVD Companies Mergers & Acquisitions
  • Collaboration, Partnership, Alliance Agreements
  • Test Services
  • Historical IVD Market vs Today
  • In the Beginning to Now
  • Future
  • Next-Generation Sequencing
  • Cancer Testing (Liquid Biopsy)
  • Companion Diagnostics
  • Point of View
  • COVID-19 Impact and Summary
  • COVID-19 Market Value
Chapter Three: The Global Picture for In Vitro Diagnostic Markets
  • Background
  • Simultaneous Threats: Chronic and Acute
  • Expected World IVD Market Developments
  • Global Population and Aging
  • Workforce Reduction
  • WHO Essential IVD List
  • Increase in Chronic Diseases
  • Emerging and Emerged Markets
  • Size and Forecast for the Global IVD Market
  • The IVD Market in the United States
  • PAMA and Reimbursement Changes
  • Impact of CARES Act on PAMA
  • LDT Oversight Update
  • Changes Resulting from COVID-19 Pandemic
  • Precision Medicine and NGS
  • IVD Market in Europe: Growing Markets
  • EU Regulation
  • Precision Medicine in Europe
  • Brexit
  • Japan
  • Eastern Europe: Growth Region
  • China: Current IVD Market
  • Clinical Laboratory Market in China
  • IVD Distribution in China
  • India: Population and Opportunity
  • Clinical Laboratory Market in India
  • IVD Regulation
  • Rest of Asia
  • Brazil
  • Disease Trends
  • Clinical Laboratory Market in Brazil
  • IVD Regulation
  • Mexico
  • The Russian Federation
  • Canada
  • Emerging Markets
  • Saudi Arabia IVD Market
  • South Africa IVD Market
  • South Korea IVD Market
  • Turkey IVD Market
  • United Arab Emirates (UAE) IVD Market
  • Other Markets to Watch
  • IVD Market Opportunity by Country
Chapter Four: Company and Industry Trends
  • Introduction
  • Advanced Medicine Without Borders
  • China Market Information
  • Direct to Consumer Genetic Test Services
  • Future Trends
  • Gene Editing
  • CRISPR as a Diagnostic Tool
  • CRISPR and the Food Industry
  • Microbiome
  • Next Generation Sequencing
  • Liquid Biopsy
  • Quality Assurance
  • Product News
  • Market Cleared Products
  • Liquid Biopsy in Microbiology
  • Liquid Biopsy Companies in 2021-2022
  • The Future for Liquid Biopsy
  • Information Technology Advances and Artificial Intelligence
  • AI in Clinical Practice
  • The Regulatory Pathway
  • Product Initiatives
  • IBM Watson Health
  • AI in Liquid Biopsy
  • Future Trends
  • Exosome Sequencing
  • Biotin Interference in Immunoassay Detection Errors
  • Traumatic Brain Injury and IVD
  • Telehealth
  • Blockchain
  • Substance Abuse
  • Opioid Epidemic
  • COVID-19 and Substance Abuse
  • Biomarkers and Substance Abuse
  • Clinical Laboratory Testing for Drugs of Abuse
  • Urine
  • Blood
  • Oral
  • Hair
  • Micro-hospital Opportunities
  • Climate Change and Infectious Disease
  • Kickback Schemes
  • Early Sepsis Detection
Chapter Five: Point-of-Care Tests
  • Overview and Trends
  • POC Industry Drivers
  • Patient focused drivers
  • Medical/Healthcare related drivers
  • Technology drivers
  • Economic drivers
  • Other drivers
  • POC Industry Challenges
  • Professional POC
  • OTC Self Testing
  • Home Collection Trend
  • Pregnancy/Fertility Tests
  • Colon Cancer Screening
  • Lipid Testing
  • Drugs of Abuse Testing
  • Products
  • Rapid and POC Infectious Disease Testing
  • Products
  • HIV and Hepatitis Testing and Monitoring
  • Tuberculosis
  • Tropical and Neglected Diseases
  • Respiratory Diseases
  • Sepsis and Nosocomial Disease
  • Sexual Health
  • Lyme Disease
  • Market Size and Growth
  • Diabetes Testing - Blood Glucose Monitoring
  • IT to Aid Diabetes Management
  • Diabetes Market Analysis
  • POC Glucose Competitors
  • Blood Glucose Self-Testing
  • Noninvasive Testing Devices
  • Continuous Glucose Monitoring
  • Blood Glucose Testing by Professionals
  • Diabetes Testing - Glycated Hemoglobin
  • Genes and Other Markers of Diabetes
  • The Major POC Test Players
Chapter Six: The Core Lab
  • Core Lab Overview and Trends
  • Connectivity
  • Overview of Chemistry Tests
  • Lab Automation
  • Market Analysis
  • Rapid Response Systems
  • Critical Care Analysis
  • User Apps
  • Urinalysis
  • The Commercial Outlook for Chemistry Tests
Chapter Seven: Immunoassays
  • Overview and Trends
  • Immunoassay Technology Continues to Evolve
  • Mass Spectrometry
  • Radioimmunoassays
  • Market Analysis
  • Leading Suppliers and Growth Potential
  • Mature Assay Segment
  • Thyroid Function
  • Therapeutic Drug Monitoring
  • Anemia
  • Toxicology/DAU
  • Allergy
  • Maturing Immunoassays
  • Proteins
  • Growth Immunoassays
  • Vitamin D
  • Tumor Markers
  • Cardiac Markers
  • Autoimmune
  • Rheumatoid Arthritis
  • Gastrointestinal Disorders
  • Transplant Management
  • Women’s Health
  • Alzheimer’s Disease
  • Traumatic Brain Injury
  • Sleep Apnea
  • Miscellaneous
  • Point-of-Care OTC and Professional Use Immunoassays
  • Pregnancy Testing
  • Cardiovascular Diagnostics
  • Drugs of Abuse/Therapeutic Drug Monitoring
  • Innovating POC
  • The Commercial Outlook for Immunoassays
Chapter Eight: Molecular Assays
  • Overview
  • Sample Preparation and Quality Control
  • Molecular Evolution
  • Exosome Sequencing
  • Liquid Biopsy
  • Metabolomic Profiling
  • Information Technology
  • Artificial Intelligence AI
  • Forensic Studies - An Emerging Opportunity
  • Test Platforms
  • Major Players
  • Market Analysis
  • Oncology
  • Inherited Diseases and Thrombophilia SNPs
  • Depression and Psychiatric Disorders
  • Prenatal and Newborn Testing
  • Transplant Diagnostics
  • The Commercial Outlook for Molecular Tests
Chapter Nine: Hematology
  • Overview of Hematology and Trends
  • Digital Image Analysis
  • Digital Evolution
  • Quality Control Measurement Programs
  • Laboratory-based Hematology Testing
  • Regional Laboratory-based Hematology Test and Instrument Market
  • Decentralized Hematology Testing
  • Hemoglobin/Hematocrit at the POC
  • Market Analysis: Leading Suppliers
  • The Commercial Outlook for Hematology Tests
Chapter Ten: Coagulation
  • Overview and Trends of Coagulation and Immunohematology Tests
  • Special Topics
  • Direct Oral Anticoagulants (DOACs)
  • D-dimer
  • Market Analysis
  • Lab-based Testing
  • Genetic Markers of Hypercoagulopathies
  • Leading Suppliers: Laboratory Systems
  • Decentralized Coagulation Testing - Professional Use
  • Decentralized Coagulation Testing - OTC
  • Platelet Testing
  • Leading Suppliers: POC Systems
  • The Commercial Market for Coagulation Tests
Chapter Eleven: Microbiology and Virology
  • The Real Impact of Infections
  • Herpes and Alzheimer’s Disease
  • Ebola and Cancer
  • HIV and Cancer
  • H pylori and Cancer
  • Bacteria and Parkinson’s
  • HPV and Cancer
  • Microbial Antibiotic Resistance - The Role of Clinical Tests
  • Fast Identification
  • Traditional Microbiology and Its Limits
  • The New Microbiology - Innovations
  • Liquid Based Microbiology and Automation Innovations
  • Post-Blood Culture Microbial ID
  • PCR and Other NAAT-Based Tests for Infectious Diseases
  • Microbiome-Related Microbiology Tests
  • Illumina
  • Bio-Rad
  • QIAGEN
  • Luminex
  • inBiome BV
  • Biohit Oyj
  • DNA Genotek
  • Biocartis
  • Abbott
  • Enterome / Nestlé Health Science
  • Thermo Fisher Scientific
  • Next Generation Sequencing-Based Microbiology Approaches
  • Syndromic/Multiplex Testing
  • New Infectious Disease Threats
  • Tickborne Diseases (TBDs)
  • Zika
  • Chagas
  • Dengue
  • Ebola
  • Chikungunya
  • Middle East Respiratory Syndrome-Coronavirus (MERS-CoV)
  • Marburg
  • Keystone
  • SARS-CoV-2 (COVID-19)
  • Monkeypox
  • Microbiology Firms Acquisitions and Collaborations
  • Market Analysis
  • Market Analysis - Traditional Microbiology ID/AST
  • Traditional ID/AST
  • Blood Culture
  • Chromogenic Media
  • Rapid Tests Performed on Colonies from Culture Media
  • Supplies
  • Market Analysis - Microbiology Immunoassays
  • Improvements in Microbiology Immunoassays
  • Hepatitis Testing
  • Sepsis
  • HIV Immunoassay Testing
  • Sexually Transmitted Diseases (STDs)
  • ToRCH
  • Lyme Disease
  • TBD-Serochip (Roche associated)
  • Rapid Immunoassay Tests
  • Market Analysis - Molecular Microbiology
  • Lab Automation and Molecular Diagnostics
  • Molecular Respiratory Infection Testing
  • The Respiratory Trio - Flu, Strep, RSV
  • Molecular Testing for Sexually Transmitted Diseases
  • Molecular Hepatitis Testing
  • Molecular HIV Testing
  • Molecular Tests for Hospital-Acquired Infections (HAIs)
  • Assessing the Problem: Nosocomial Infection Statistics
  • Clostridium Difficile
  • MRSA
  • Molecular TB Testing
  • Limitations of Molecular Microbiology Testing
  • Mass Spectrometry
  • The Future Outlook for Microbiology
Chapter Twelve: Blood Banking Services
  • Overview
  • The Current Status of Global Blood Collection
  • Global Blood Safety
  • Zika Virus
  • Blood and Component Collection
  • COVID-19 Impact on Plasma Collection
  • Reevaluating Blood Transfusions
  • Blood Typing and Grouping Market
  • Manual Blood Typing Methods
  • Automated Blood Typing and Screening Methods
  • Molecular Methods
  • Size and Growth of Typing Markets
  • Blood Typing Market by Geography
  • Blood Testing Market
  • Preventing Bacterial Infections
  • Immunoassays
  • Nucleic Acid Testing (NAT)
  • Size and Growth of the Market
  • Blood Testing Market by Geography
  • The Commercial Outlook for Blood Banking Testing
Chapter Thirteen: Histology and Cytology
  • Overview
  • Special Topics
  • Histology Automation
  • Advanced Analysis Solutions
  • HPV meets Core Lab
  • Market Analysis
  • Total Market
  • Regional Market Analysis
  • Traditional Stains
  • Pap Testing
  • Immunohistochemistry and In Situ Hybridization
  • Pharmacodiagnostic Histology
  • Digital Imaging and Computational Pathology
  • COVID-19 and Digital Pathology
  • Circulating Tumor Cells
  • Flow Cytometry
  • The Commercial Outlook for Histology and Cytology Tests
Chapter Fourteen: Company Profiles: The Top Tier
  • Abbott Diagnostics
  • Core Lab
  • Hematology
  • Blood Banking
  • Infectious Diseases - Molecular
  • Diabetes
  • HIV Point of Care
  • i-STAT Business
  • Companion Diagnostic Testing
  • Liquid Biopsy
  • Agilent Technologies
  • Genomics
  • Cytogenetic Analysis
  • Sequencing
  • CRISPR
  • Flow Cytometry
  • Companion Diagnostics - Dako
  • Beckman Coulter, Inc. / Danaher
  • Hematology
  • Hematology IT
  • Clinical Chemistry
  • Immunoassays
  • Microbiology
  • IT Clinical
  • Flow Cytometry
  • Blood Banking
  • Beckman Coulter Life Sciences
  • Becton, Dickinson and Company (BD)
  • Cytology
  • Molecular Microbiology
  • Traditional Microbiology - ID/AST
  • Blood Culture
  • Hospital Acquired Infections
  • Blood Collection
  • Mass Spectrometry
  • Flow Cytometry
  • bioMérieux Inc.
  • Traditional Microbiology
  • Blood Culture
  • Immunoassays
  • Mass Spectrometry
  • BioFire Diagnostics Business
  • Expansion
  • Bio-Rad Laboratories, Inc.
  • Quality Control
  • Blood Bank
  • Diabetes
  • Immunoassays
  • Liquid Biopsy
  • Droplet Digital PCR
  • Sequencing
  • Bruker Corporation
  • Acquisitions and Collaborations
  • Mass Spectrometry
  • Microbiology
  • Molecular PCR
  • Cepheid / Danaher
  • GeneXpert Xpress Line
  • Tuberculosis
  • Microbiology
  • POC Testing
  • Cancer
  • Danaher Corporation
  • Acquisitions
  • DiaSorin S.p.A
  • Development Plan
  • Expansion
  • Immunoassays
  • Molecular
  • Molecular Oncology
  • Grifols S.A.
  • Blood Transfusion Business
  • ABO Blood Typing
  • Molecular ABO Blood Typing
  • Immunoassays
  • Coagulation
  • Market Expansion
  • Hologic, Inc.
  • Acquisitions
  • PANTHER Molecular System
  • HIV Testing
  • Sexually Transmitted Infections
  • Infectious Diseases
  • Panther Fusion
  • Cytology
  • Instrumentation Laboratory (IL) / Werfen
  • Expansion
  • Coagulation
  • Acute Care
  • Information Technology
  • Leica Biosystems/Danaher
  • Digital Pathology
  • Companion Diagnostics
  • Stain Reagents
  • Lab Systems
  • Sample Handling
  • Circulating Tumor Cells (CTCs)
  • Artificial Intelligence
  • Ortho Clinical Diagnostics (QuidelOrtho)
  • Blood Bank
  • Core Lab / Immunoassays
  • Expansion
  • PerkinElmer, Inc. (PE)
  • Diagnostics
  • Sequencing /Genomics
  • Liquid Biopsy
  • Histology
  • Prenatal Business
  • Lab Services
  • Mass Spectrometry
  • QIAGEN
  • Tuberculosis
  • Molecular Expansion
  • Precision Medicine / Companion Diagnostics
  • Molecular Microbiology
  • Prenatal Testing
  • Next Generation Sequencing
  • Sample Prep, Informatics
  • Digital PCR
  • Liquid Biopsy
  • Cervical Cancer
  • Expansion
  • Quidel Corporation (QuidelOrtho)
  • Immunoassays
  • Rapid Immunoassays
  • The Solana Business
  • Molecular - Savanna
  • Radiometer A/S / Danaher
  • Critical Care
  • Immunoassays
  • HemoCue
  • Transcutaneous Monitoring
  • Roche Diagnostics
  • Hematology
  • Immunoassays
  • HIV
  • Molecular Expansion
  • Core Molecular
  • Digital PCR
  • Diabetes Care
  • Coagulation
  • cobas Liat System - POC
  • HPV
  • Blood Bank
  • Transplant Medicine
  • Cancer Companion Testing
  • IT in Anatomical Pathology
  • Information Technology
  • Siemens Healthineers (Siemens)
  • Core Lab
  • Lab Automation
  • Immunoassays
  • Hematology
  • Urinalysis
  • Molecular
  • Expansion to Support Molecular Diagnostics - Fast Track Diagnostics
  • Sequencing with Artificial Intelligence
  • Acute Care - POC
  • POC Connectivity
  • Business Expansion
  • Sysmex Corporation
  • Hematology
  • Coagulation
  • Urinalysis
  • Immunoassays
  • Lab Information System
  • Information Technology
  • Flow Cytometry
  • Precision Medicine / Companion Test Diagnostics
  • Liquid Biopsy
  • Oncology
  • Sysmex Inostics
  • Forging New Markets
  • Thermo Fisher Scientific Inc.
  • Immunoassays
  • Microbiology
  • Molecular Test Business
  • Next Generation Sequencing
  • qPCR
  • Oncology Companion Diagnostics
  • Transplant Medicine
  • Microbiome
  • Mass Spectrometry
  • Collaborations
  • Gene Editing and Cell Therapy
  • China
  • Ventana Medical Systems Inc. / Roche Tissue Diagnostics
  • Immunohistochemistry - IHC
  • Cervical Cancer Screening
  • Companion Diagnostics
  • Werfen
Chapter Fifteen: Company Profiles: The Second Tier
  • ARKRAY
  • Dry Chemistry / Immunoassays
  • Urinalysis
  • Diabetes
  • Molecular
  • BGI Genomics (formerly Beijing Genome Institute)
  • PCR - Fluorescence
  • MGI Tech Co., Limited, China
  • Prenatal Testing
  • Test Services
  • Whole Genome Sequencing (WGS)
  • Collaborations
  • Cue Health
  • Dexcom
  • Diagnostica Stago S.A.S.
  • Eiken Chemical Co. Ltd
  • Product News
  • Exact Sciences
  • Fulgent Genetics, Inc
  • Fujirebio Diagnostics, Inc.
  • GenMark Diagnostics, Inc
  • Guardant Health, Inc.
  • Horiba Medical
  • Illumina
  • China
  • Invitae
  • Labcorp, Laboratory Corporation of America
  • Precision Medicine
  • Diagnostics Services
  • DTC Home Testing
  • Collaborations and Expansion
  • Luminex Corporation (DiaSorin)
  • Masimo Corporation
  • Menarini Diagnostics
  • Meridian Bioscience, Inc.
  • Immunoassays
  • Molecular Tests
  • Mindray - Shenzhen Mindray Bio-medical Electronics Co., Ltd.
  • Natera
  • Myriad Genetics, Inc.
  • Nihon Kohden
  • Nova Biomedical Corporation (Nova)
  • OraSure Technologies, Inc.
  • Philips (Royal Philips)
  • Histology
  • Precision Medicine
  • Precision Medicine IT
  • Patient Monitoring
  • Point of Care
  • Wearable Self Monitor
  • Quest Diagnostics
  • Diagnostic Services
  • Oncology
  • Infectious Diseases
  • Prenatal and Women’s Health
  • Retail / Consumer Health
  • Expansion
  • Randox Laboratories Ltd.
  • Clinical Chemistries
  • Controls
  • Evidence Series - Multistat Biochip Analyzers
  • Molecular
Chapter Sixteen: Company Profiles: Blood Bank Specialists
  • Cerus Corporation
  • Quotient Limited
Chapter Seventeen: Company Profiles: Core Lab and Other Companies
  • AB SCIEX Pte Ltd.
  • EKF Diagnostics Holdings Plc
  • ELITech Group S.A.S.
  • Nova Biomedical
  • Sekisui Diagnostics LLC
  • Shimadzu Scientific Instruments
  • Snibe Co. Ltd., (Shenzhen New Industries Biomedical Engineering Co. Ltd.)
  • Tosoh Bioscience
  • Trinity Biotech Plc
Chapter Eighteen: Company Profiles: CTC & Liquid Biopsy Test Providers
  • Biocartis
  • Biocept, Inc.
  • Biodesix
  • Epic Sciences
  • Epigenomics AG
  • Foundation Medicine, Inc.
  • Menarini-Silicon Biosystems
  • NeoGenomics
Chapter Nineteen: Company Profiles: Specialists
  • Ascensia Diabetes Care Holdings AG
  • Bigfoot Biomedical Inc.
  • Debiotech SA
  • Glooko Inc.
  • Insulet Corporation
  • Integrity Applications Inc. (GlucoTrack)
  • LifeScan Inc.
  • Medtronic plc
  • Nemaura Medical Inc.
  • Verily Life Sciences LLC
Chapter Twenty: Company Profiles: Hematology (Cell Analysis) and Coagulation Specialists
  • CellaVision AB
Chapter Twenty-One: Company Profiles: Histopathology Specialists
  • Amoy Diagnostics Co. Ltd.
  • Applied Spectral Imaging Inc. (ASI)
  • BioGenex Laboratories, Inc.
  • BioView Ltd.
  • Leica Biosystems
  • MilliporeSigma
  • Visiopharm
Chapter Twenty-Two: Company Profiles: Immunoassay Specialists
  • Biohit Healthcare
  • Biomerica Inc.
  • Bio-Techne Corporation
  • Eurobio Scientific
  • EUROIMMUN AG
  • Immunodiagnostic Systems (IDS)
  • INOVA Diagnostics, Inc.
  • One Lambda, Inc
  • Response Biomedical Corp.
  • Theradig
  • VolitionRx Limited
Chapter Twenty-Three: Information Technology Specialists in In Vitro Diagnostics
  • Cerner Corp. (Oracle)
  • Dell Technologies Inc.
  • Euformatics Oy
  • GenomOncology LLC
  • Google LLC
  • Intel Corporation
  • International Business Machines Corp. (IBM)
  • PierianDx
  • SOPHiA GENETICS SA
Chapter Twenty-Four: Company Profiles: Microbiology Specialists
  • Accelerate Diagnostics, Inc.
  • Advanced Biological Laboratories, S.A. (ABL)
  • altona Diagnostics
  • ArcDia International Oy Ltd.
  • BioFire Diagnostics, LLC. (Acquired by bioMérieux)
  • COPAN ITALIA S.p.A. and COPAN Diagnostics, Inc.
  • Curetis
  • Genetic Analysis AS
  • Greiner Bio-One International GmbH
  • Mast Group
  • Mobidiag
  • Q-linea AB
  • OpGen, Inc.
  • Seegene, Inc.
  • T2 Biosystems
Chapter Twenty-Five: Company Profiles: Molecular Test Specialists
  • Asuragen Inc.
  • Enzo Biochem Inc.
  • Fluidigm Corporation (Standard BioTools)
  • Genome Diagnostics BV (GenDx)
  • NanoString Technologies, Inc.
  • Pacific Biosciences of California, Inc. (PacBio)
  • Takara Bio Inc.
  • Vela Diagnostics
Chapter Twenty-Six: Company Profiles: Point of Care Test Specialists
  • Abingdon Health Ltd.
  • binx Health
  • Biomeme, Inc.
  • Chembio Diagnostic Systems, Inc.
  • Diazyme
  • DNA Electronics Ltd (DNAe)
  • Genedrive plc (formerly Epistem Holdings)
  • NuGenerex Diagnostics (HDS)
  • Immunostics, Inc.
  • Loop Medical
  • MedMira, Inc.
  • QuantuMDx Group, Ltd.
  • Rheonix, Inc.
  • Veredus Laboratories Pte Ltd
Chapter Twenty-Seven: Company Profiles: Prenatal Test Service Providers
  • Berry Genomics Co. ltd.
  • CooperGenomics (Division of CooperSurgical)
  • INEX Innovate
  • Oxford Gene Technology
  • Sequenom, Inc. (Integrated Genetics)
  • Yourgene Health
Chapter Twenty-Eight: Company Profiles: Quality Control & Sample Pretreatment Specialists
  • 10x Genomics
  • Agena Bioscience, Inc.
  • Biotype Diagnostic GmbH
  • DxTerity Diagnostics Inc.
  • Horizon Discovery Group plc
  • IncellDx
  • LGC SeraCare Life Sciences, Inc.
  • PreAnalytiX GmbH
  • Precipio, Inc. (formerly Transgenomic)
  • Quanterix Corporation
  • Randox Laboratories Ltd.
  • Clinical Chemistries
  • Controls
  • Evidence Series - Multistat Biochip Analyzers
  • Molecular
  • Streck Inc.
Chapter Twenty-Nine: Test Service Providers
  • 23andMe
  • Agendia BV
  • Ambry Genetics
  • ARUP Laboratories
  • Aspira Women’s Health ( formerly Vermillion Inc.)
  • BioReference Laboratories
  • Biotheranostics
  • BluePrint Genetics Oy
  • Boston Heart Diagnostics
  • CareDx, Inc.
  • Helomics Corporation
  • Mayo Clinic Laboratories
  • MDxHealth SA
  • OPKO Diagnostics
  • Sonic Healthcare
  • Veracyte, Inc.
List of Tables
Table 1-1: Exchange Rate Fluctuations, 2018-2022
Table 1-1a: Global In Vitro Diagnostic Sales by Product Market, 2022-2027 ($ million) (Clinical Chemistry; Immunoassays- non isotopic: Infectious disease, Other immunoassays, Blood bank screening, Drugs of Abuse, Diabetes HbA1c - lab; Hematology - Core Lab; Microbiology (ID/AST); Microbiology (molecular); Microbiology - Mass Spectrometry; Coagulation (PT/INR); Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular - NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry) and COVID-19 Dx 2022
Table 1-1b: Global In Vitro Diagnostic Products, Markets of Interest, 2022-2027 (Sequencing - clinical, Prenatal Test Services, DTC Genetic Testing, Flow Cytometry, Drugs of Abuse: Employment (non-IVD), and Drugs of Abuse: Criminal)
Table 2-1a: Global In Vitro Diagnostic Sales by Product Market, 2022-2027 ($ million) (Clinical Chemistry; Immunoassays- non isotopic: Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c - lab; Hematology - Core Lab; Microbiology (ID/AST); Microbiology (molecular); Microbiology - Mass Spectrometry; Coagulation (PT/INR); Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular - NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry) and COVID-19 Dx 2022
Table 2-1b: Global In Vitro Diagnostic Products, Markets of Interest, 2022-2027 (Sequencing - clinical, Prenatal Test Services, DTC Genetic Testing, Flow Cytometry, Drugs of Abuse: Employment (non-IVD), and Drugs of Abuse: Criminal)
Table 2-2: Clinical Diagnostic Revenues of Selected Top 20 IVD Companies*, 2021 and estimated 2022 ($ million)
Table 2-3: Revenues of Selected Top 20 Niche Players, 2021 and estimated 2022 ($ million, estimated) *
Table 2-4: Selected IVD Mergers and Acquisitions 2019-2022 (first half)
Table 2-5: Selected IVD Partnerships/Collaborations/Alliance Agreements 2016-2019
Table 2-6: Selected Test Services, Sales 2017-2021 ($ millions, estimated where applicable)
Table 2-7: Global Lab Market Segmentation, 2021 ($ billions)
Table 2-8: Revenues for a Selection of U.S.-based Reference Labs, 2017-2021 ($ million, estimated)
Table 2-9: Estimated Clinical Test Volume by Select Independent Laboratory, 2021 (millions of units)
Table 2-10: Estimated COVID-19 Test Volume by Select Independent Laboratory, 2021 (millions of units)
Table 2-11: COVID-19 Market Estimates by Segment (Immunoassay, Molecular, Rapid - POC), 2022 ($ millions)
Table 3-1: Elderly Support Ratio in Various Countries (Australia; Brazil; Canada; China; China, Hong Kong SAR; France; Germany; India; Italy; Japan; Mexico; Saudi Arabia; Singapore; South Africa; Spain; Turkey; United Kingdom; United States; World)
Table 3-2: Age Under 15 and Over 65, by Continent (Africa, L. America/Caribbean, Asia, Oceania, N. America, Europe, World) 2020
Table 3-3: WHO Model List of Essential In Vitro Diagnostics (EDL)
Table 3-4: Individual EUAs for Molecular Tests for SARS-CoV-2
Table 3-5: Authorized Molecular-Based Laboratory Developed Tests for Detection of Nucleic Acid from SARS-CoV-2
Table 3-6: Individual EUAs for Antigen Diagnostic Tests for SARS-CoV-2
Table 3-6: Individual EUAs for Serology Tests for SARS-CoV-2
Table 3-7: Individual EUAs For IVDs for Management of COVID-19 Patients
Table 3-8: Market Potential by Total Population, and Percent Urban 2020 (China, India, United States, Brazil, Russia, Mexico, Turkey, S. Korea, S. Africa, Vietnam, Poland, Saudi Arabia, Canada, Colombia, Ukraine, Egypt, Malaysia, Peru, and Chile)
Table 3-9: Global In Vitro Diagnostic Market; Major Country/Region Markets, 2022 and 2027 ($ millions) (United States, EU 15/W. Europe, Japan, China, Canada, India, Eastern Europe, Brazil, Peru, Mexico, Saudi Arabia, Turkey, UAE, Vietnam, Russia, South Africa, South Korea, Australia, ROW)
Table 3-10: Global In Vitro Diagnostic Market; Regional Markets, 2022 and 2027 ($ millions) (North America, Europe, Asia Pacific, Latin America, ROW)
Table 3-11: Global In Vitro Diagnostic Market - YOY Growth 2021-2022
Table 3-12: Global In Vitro Diagnostic Market; Regional Markets, 2021-2022 YOY Growth (North America, Europe, Asia Pacific, Latin America, ROW)
Table 3-13: United States IVD Market Share by Segment, 2022 (%) (Clinical Chemistry, Microbiology ID/AST, Microbiology Molecular, POC Diabetes, POC Other, Immunoassay Infectious Disease, Immunoassay Other, Nucleic Acid Assays, Coagulation, Histology, Hematology, Blood Grouping, Others), Total Market Value $54,033 million; Clinical Sequencing $2,916 million ($ millions)
Table 3-14: Proposed Clinical Diagnostic Laboratory Test Rates, 2020-2025
Table 3-15: Economic Indicators (GDP Growth, Inflation Growth) by Select European Country (Germany, France, Italy, Spain), 2020-2023 (%)
Table 3-16: Western European IVD Market by Country, 2022 ($ millions, estimated) (Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, UK)
Table 3-17: IVD Market Per Capita, Europe, 2021/2022 Estimates (Switzerland, Germany, Netherlands, Sweden, France, Slovenia, United Kingdom, Italy, Spain, Slovakia, Greece, Croatia, Czech Republic, Hungary, Poland, Romania, Bulgaria, Russia, Ukraine)
Table 3-18: Japan IVD Market by Segment, 2022 (%) (Clinical Chemistry, Microbiology ID/AST, Microbiology Molecular, POC Diabetes, POC Other, Immunoassay Infectious Disease, Immunoassay Other, Coagulation, Histology, Hematology, Others)
Table 3-19: Eastern European IVD Market by Country, 2022 ($ millions) (Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Slovakia, Slovenia, Ukraine, Other)
Table 3-20: China IVD Market by Segment, 2022 (%) (Clinical Chemistry, Microbiology ID/AST, Microbiology Molecular, POC Diabetes, POC Other, Immunoassay Infectious Disease, Immunoassay Other, Coagulation, Histology, Hematology, Others)
Table 3-21: Total Midyear Population by Broad Age Group: China (million persons), 2010-2050
Table 3-22: India IVD Market by Segment, 2022 (%) (Clinical Chemistry, Hematology, Coagulation; Microbiology; POC Diabetes; POC Other; Immunoassay; Histology; Others)
Table 3-23: Asia Pacific IVD Market by Country, 2022 ($ millions) (Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam)
Table 3-24: Brazil IVD Market by Broad Segment, 2022 (%) (Clinical Chemistry, Microbiology, POC Diabetes, POC Other, Immunoassay, Histology, Others)
Table 3-25: Mexico IVD Market by Broad Segment, 2022 (%) (Clinical Chemistry, Microbiology, POC, Immunoassay, Histology, Others)
Table 3-26: IVD Market Opportunity by Country (2022 Market Rank, Country CAGR 2022-2027) (China, Philippines, Brazil, Israel, Malaysia, India, Mexico, Indonesia, Chile, Poland, Saudi Arabia, South Korea, Romania, Colombia, United Arab Emirates, Argentina, Hungary, Vietnam, Iraq, Peru, Japan, France, Turkey, Egypt, Singapore, Luxembourg, Croatia, Jordan, U.S., Germany, United Kingdom, Canada, Spain, Russia, Netherlands, Switzerland, Belgium, Sweden, Austria, Denmark, Ireland, Finland, Iran, Thailand, Venezuela, Italy, Australia, Portugal, Greece, Czech Republic, South Africa, Norway, Bulgaria, Slovakia, Slovenia)
Table 4-1: Key Emerging IVD Markets (Brazil, Russia, India, China, South Korea, Mexico, Turkey, Vietnam) 2017-2022 ($millions)
Table 4-2: Selected Gene Editing / CRISPR Innovations
Table 4-3: Selected Microbiome Test Innovations
Table 4-4: Selected Clinical NGS Platforms on the Market
Table 4-5: Selected AI Market Cleared Tests
Table 4-6: Selected AI Product Initiatives in Development and Collaborations
Table 4-7: Selected AI/Liquid Biopsy Initiatives
Table 4-8: Biotin-free Offerings Currently on the Market
Table 4-9: Global Drug Abuse Statistics
Table 4-10: Selected Opioid Test FDA Approvals
Table 5-1 Professional POC Test Sales by Category, Worldwide 2022 -2027 ($million) (Glucose, Critical Care POC, Fertility, Infectious Diseases, Cardiac Markers, Cholesterol, Coagulation, HbA1c POC, Hematology, Fecal Occult Blood, Drugs of Abuse, Others)
Table 5-2: Selected Professional POC Test Innovations (excluding COVID-19 testing)
Table 5-3: POC Self-Test Sales by Category, Worldwide, 2022-2027($million) (Glucose, Self; Glucose, Continuous; Pregnancy; Coagulation; Fecal Occult Blood; Drugs of Abuse; H. pylori; HIV; Cholesterol; Urinalysis; Other [TSH, Allergy, Autoimmune, etc.])
Table 5-4: Home Collection Test Market*, 2022 and 2027 ($million), CAGR 2022-2027
Table 5-5: Home Collection Test Kit Market by Category, Worldwide, 2022(% Estimated Share)
Table 5-6: Selected Molecular Tests EUAs for Home Collection SARS-CoV-2 Tests
Table 5-7: POC Pregnancy and Fertility Test Market Distribution by End User, 2022 (%) (OTC, PRO)
Table 5-8: Pregnancy/Fertility POC Test Sales Distribution by Global Region, 2022 (United States, Europe, Japan, RoW)
Table 5-9: Selected POC Colon Cancer Tests
Table 5-10: Colon Cancer POC Test Sales Distribution by Global Region, 2022 (United States, Europe, Japan, RoW)
Table 5-11: Lipid POC Test Sales Distribution by Global Region, 2022 (United States, Europe, Japan, RoW)
Table 5-12: POC Drugs of Abuse Test Sales Distribution by Setting, 2022 (Employment Screening, Criminal Justice, Critical Care - Traditional POC)
Table 5-13: Drugs of Abuse Tests on the Market
Table 5-14: Innovations in Molecular POC Infectious Disease Diagnostics
Table 5-15: Innovations in Molecular POC Infectious Disease Diagnostics
Table 5-16: Infectious Disease POC Test Demand by Type, 2022 (Influenza, HIV, STD, Hepatitis, Malaria, C.Difficile, E.coli, H.pylori, Home Test/OTC, Others)
Table 5-17: Infectious Disease POC Test Sales Distribution by Global Region, 2022 (United States, Europe, Japan, RoW)
Table 5-18: Glucose POC Test Sales Distribution by Global Region, 2022 (United States, Europe, Japan, RoW)
Table 5-19: Selected Apps and Glucose Management IT
Table 5-20: Global Diabetes Sales by Test Category, 2022-2027 (Glucose, OTC; Glucose, professional; Glucose, continuous; HbA1c, POC; TOTAL; HbA1c, Lab) ($ millions)
Table 5-21: POC Test Revenues of Selected IVD Glucose Companies, 2022 ($ million, estimated)
Table 5-22: Selected Glucose Self-Test Meter Innovations
Table 5-23: Selected Noninvasive Glucose Monitoring Devices
Table 5-24: Selected Continuous Blood Glucose System Developments
Table 5-25: Selected Innovations in Hospital-based Glucose Monitoring
Table 5-26: Global HbA1c Test Sales Market and Distribution by Setting, 2022-2027 ($ millions) (HbA1c POC, HbA1c Lab)
Table 5-27: Selected POC HbA1c Devices
Table 5-28: Selected POC Diabetes Monitoring Tests
Table 5-29: POC Test Revenues of Selected IVD Companies, 2022 ($ million, estimated)
Table 6-1: Selected Analytes for the Core Lab
Table 6-2: Global Clinical Chemistry Sales by Test Category, 2022-2027 ($millions) (General Chemistries, Blood Gases, Urinalysis)
Table 6-3: Global Clinical Chemistry Sales Distribution by Region, 2022 (North America, Europe, Asia Pacific, RoW)
Table 6-4: Major Clinical Chemistry Companies (Blood gas/electrolyte, general chemistries, UA)
Table 6-5: Selected Clinical Chemistry Innovations
Table 6-6: Selected Major Whole Blood Chemistry Analyzers
Table 6-7: Blood Gas, Electrolyte and Critical Care Instrument Market by End User, 2022 and 2027 (Lab-based, POC-based) (in $ millions)
Table 6-8: Blood Gas, Electrolyte, and Critical Care Market Leaders including POC, 2022 (percent distribution of total sales)
Table 6-9: Selected Apps, Critical Care and Urinalysis IT Innovations
Table 6-10: UA Market by End User, 2022 and 2027 (Lab-based, POC-based)
Table 6-11: Urinalysis Systems (including POC) Market Leaders, 2022 (percent distribution of total sales) estimated
Table 6-12: Selected Urinalysis Innovations
Table 7-1: Selected Immunoassay Technologies
Table 7-2: Selected Innovation in Mass Spectrometry for Routine Analyses
Table 7-3: Global Lab-based Immunoassay (excluding infectious disease and blood screening) Sales, by Analyte Type, 2022-2027 ($millions) (Cardiac Markers, Tumor Markers, Autoimmune, Diabetes/HbA1c, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs, Drugs of Abuse, Vitamin D, Total; w/o HbA1c)
Table 7-4: Global Immunoassay (excluding infectious disease and blood screening) Sales Distribution by Region, 2022 (%) (North America, Europe, Japan, Asia Pacific, RoW)
Table 7-5: IVD Quality Control Market (estimated), 2022 ($millions)
Table 7-6: Selected Immunoassay Quality Control Products
Table 7-7: 2021-2022 Revenues of Leading Lab-based Immunoassay Vendors (in millions $), Estimated
Table 7-8: Selected Vitamin D Immunoassays
Table 7-9: Selected Tumor Marker Innovations
Table 7-10: Selected Cardiac Marker Innovations
Table 7-11: Selected Autoimmune Test Innovations
Table 7-12: Selected Arthritis Immunoassay Innovations
Table 7-13: Selected Inflammatory Bowel Disease Test Innovations
Table 7-14: Selected Immunoassays for Transplant Medicine
Table 7-15: Selected Women’s Health Innovations
Table 7-16: Selected Innovations for Alzheimer’s Disease Immunoassays
Table 7-17: Selected Immunoassay Innovations
Table 7-18: Global POC Immunoassay Sales Distribution by Region, 2022 (United States, Europe, Japan, RoW)
Table 7-19: Global POC Immunoassay Test Sales by Test Category, 2022-2027 (millions $) (OTC/Self Tests: Pregnancy/Ovulation, Drugs of Abuse, HIV, H. pylori, Infectious Disease/COVID-19, Other, OTC/Self Total; professional POC: Cardiac Markers, Drugs of Abuse, HbA1c, Pregnancy, Infectious Disease/COVID-19, Other, Professional Total)
Table 7-20: Selected Self-Test Immunoassay Innovations
Table 7-21: Selected POC Test Innovations
Table 7-22: Selected POC Immunoassay Test Platforms
Table 8-1: Common Next Generation Molecular Test Traits
Table 8-2: Selected Molecular Test Sample Preparation and QC Innovations
Table 8-3: Selected Exosome Test Innovations
Table 8-4: Selected Liquid Biopsy Innovations
Table 8-5: Selected IT Innovations in Molecular Diagnostics
Table 8-6: Selected Innovations in Forensic DNA Testing
Table 8-7: Key Molecular Technologies and Major Players
Table 8-8: Selected Molecular Test Platform Innovations
Table 8-9: Molecular Test Revenues of Selected IVD Vendors, 2016-2021, 2022 estimated (in millions $)
Table 8-10: Global Genomic, HLA and Oncology Molecular Test Sales by Type with NIPT 2022-2027 (in millions $)
Table 8-11: Global Molecular Cancer Test Sales Distribution by Region, 2022 (North America, Europe, Asia Pacific, RoW)
Table 8-12: Selected Molecular Tumor Marker Test Innovations
Table 8-13: Most Frequently Requested Genetic Tests
Table 8-14: Global Molecular Thrombophilia Assay Sales Distribution by Region, 2022 (North America, Europe, Asia Pacific, RoW)
Table 8-15: Selected Genomic Tests for Inherited Diseases
Table 8-16: Global Prenatal Test Sales Distribution by Region, 2022 (North America, Europe, Asia Pacific, RoW)
Table 8-17: Selected Prenatal Services Provided
Table 8-18: Selected Molecular Tests for Prenatal Analysis
Table 8-19: Global Molecular HLA Testing Sales Distribution by Region, 2022 (North America, Europe, Asia Pacific, RoW)
Table 8-20: Selected Innovations of Molecular Transplant Diagnostics
Table 9-1: Hematology Analyzer Distribution of Sales by Menu Capability, 2022 estimated
Table 9-2: Lab-based Hematology Sales by Analyte Average Annual Distribution %
Table 9-3: Selected Hematology Image Analysis Innovations, 2014-2022
Table 9-4: Selected Quality Control Hematology FDA Registrations, 2021
Table 9-5: Selected Hematology Innovations, 2014-2022
Table 9-6: Global Laboratory-based Hematology Test and Instrument Market, 2022 and 2027 ($ millions)
Table 9-7: Global Laboratory-based Hematology Test and Instrument Market, by Region, 2022 (North America, Europe, Asia Pacific, RoW)
Table 9-8: POC Hematology Distribution by Specialty (hematocrit/hemoglobin vs. other routine hematology (WBC, erythrocyte, platelet)
Table 9-9: Selected POC Hemoglobin and Hematocrit Systems
Table 9-10: Selected POC Hematology Analyzer Systems
Table 9-11: Decentralized Hematology Test and Instrument Market, 2022 and 2027($ millions) (Instruments, lab-style; Handheld devices)
Table 9-12: Top Hematology Company Revenues (laboratory and POC), 2022 ($ millions)
Table 9-13: Global Hematology (Laboratory-based and POC) Sales Distribution by Region, 2022 (North America, Europe, Asia Pacific, RoW)
Table 10-1: Major Anticoagulants
Table 10-2: Global D-dimer Sales Distribution by Region, 2022 (North America, Europe, Asia Pacific, RoW)
Table 10-3: Global Coagulation Sales by Segment, 2022-2027 ($millions) (PT/INR Labs, Molecular, Professional POC, Professional Self; D-dimer)
Table 10-4: Global Coagulation Test and Instrument Market by Region, 2022 (North America, Europe, Asia Pacific, RoW)
Table 10-5: Selected Lab-based Coagulation Innovations
Table 10-6: Related CMS Codes for Reimbursement National Limits, Molecular, 2022
Table 10-7: Global Molecular - Thrombophilia SNP Sales Distribution by Region, 2022 (North America, Europe, Asia Pacific, RoW)
Table 10-8: Selected Molecular Coagulation Test Innovations
Table 10-9: Top Coagulation Company Revenues, Laboratory-based - 2022 ($ millions) est.
Table 10-10: Selected POC Coagulation Test Innovations
Table 10-11: Selected Platelet Activity Test Innovations
Table 10-12: Top Coagulation Company Revenues, POC - 2022 ($ millions) est.
Table 10-13: Major Anticoagulants Uses and Tests
Table 11-1: Selected Companies Developing Faster Identification, Some Also with Antimicrobial Susceptibility/Resistance Tests
Table 11-2: Selected Nucleic Acid Amplification Test and Other Molecular Companies in Microbiology
Table 11-3: Selected Microbiome-Based Tests
Table 11-4: Selected Companies Applying DNA/RNA Sequencing to Microbiology
Table 11-5: Selected Companies Marketing Products Addressing Emerging Infectious Disease Threats
Table 11-6: Global Microbiology Sales Distribution by Region, 2022 (North America, Europe, Asia Pacific, RoW)
Table 11-7: Global Microbiology ID/AST Market, 2022-2027 (in millions USD) (ID/AST Auto, ID/AST Panels, Blood Culture, Chromogenic Media, Rapid Microbiology; ID/AST Supplies)
Table 11-8: Global ID/AST Testing Sales Distribution by Region, 2022 (North America, Europe, Asia Pacific, RoW)
Table 11-9: Global ID/AST Testing, Distribution by Systems, 2022 (%) (Panel, Auto)
Table 11-10: Selected Advanced Techniques in Positive Blood Culture
Table 11-11: Selected Infectious Disease Immunoassay Innovations
Table 11-12: Global Clinical Laboratory-Based Microbiology/Infectious Disease Immunoassay Market by Pathogen, 2022 (in $ millions) (Hepatitis, HIV, STDs, ToRCH, Respiratory, HAIs/Sepsis, Parasitology, Mycology, Lyme disease, Other, COVID-19) est.
Table 11-13: Global Laboratory-Based Microbiology/Infectious Disease Immunoassay Market Distribution (by %) by Region, 2022 (North America, Europe, Asia Pacific, RoW)
Table 11-14: Selected HIV Assays
Table 11-15: Global Rapid Immunoassay Testing Market, Sales Distribution by Pathogen, 2022 (%) (Influenza, HIV, STD, Hepatitis, Malaria, C.Difficile, E.coli, H.pylori, Home Test/OTC, Others)
Table 11-16: Global Molecular Microbiology Sales Distribution by Region, 2022 (%) (North America, Europe, Asia Pacific, RoW)
Table 11-17: Global Molecular Microbiology Market, by Pathogen/Disease Indication, 2022-2027(in $ millions) (HAI, HIV, Hepatitis, GC/Chlamydia, Respiratory, Organism ID, Mycobacteria/TB, Others; Blood Bank Screening)
Table 11-18: Selected Automated Molecular Test Instrument Platforms
Table 11-19: Selected Molecular Point of Care Innovations in Microbiology
Table 11-20: Innovations in Molecular POC Diagnostics for HIV
Table 11-21: Frequency of the Most Common Nosocomial Infections
Table 11-22: Selected Companies Marketing Mass Spectrometers and/or Assays for the Clinical Laboratory [CE-Marked and/or 510(k) cleared]
Table 12-1: Laboratory Screening of Blood Donations for Transfusion-Transmissible Infections, Number of Countries (Syphilis, HCV, HBV, HIV, Chagas, Malaria, HTLV I/II)
Table 12-2: Prevalence of TTIs in Blood Donations [Median (Interquartile range)], by Income Group
Table 12-3: Blood Component Usage for Selected Conditions
Table 12-4: Red Blood Cell and Platelet Use by Hospital Services (%)
Table 12-5: Impact of Alloimmunization (% of Patients Screening Positive for One or More Antibodies)
Table 12-6: Selected Blood Typing and Grouping Innovations
Table 12-7: Global Blood Typing Market, 2022-2027 (Typing) (in $ millions)
Table 12-8: Global Blood Typing Sales Distribution by Region, 2022 (%) (North America, Europe, Asia Pacific, RoW)
Table 12-9: Selected Blood Testing Innovations
Table 12-10: Global Blood Banking Diagnostics Market, 2022-2027 (Immunoassay Screen, NAT Screens) (in $ millions)
Table 12-11: Global Blood Testing Market by Geography, 2022 (%) (North America, Europe, Asia Pacific, RoW)
Table 12-12: Global Blood Testing Market by Country, 2022 (%) (United States, Canada, Germany, United Kingdom, France, Japan, China, Latin America) est.
Table 13-1: Selected Histology Lab Automation
Table 13-2: Histology Information Technology Tools
Table 13-3: Selected Advanced Histology Techniques
Table 13-4: Global HPV Test Sales Distribution by Region, 2022 (%) (North America, Europe, Asia Pacific, RoW)
Table 13-5: Selected HPV Test Innovations
Table 13-6: Global Histology/Cytology Sales by Type, 2022-2027 ($ millions) (Pap Tests, in situ hybridization, immunohistochemistry, traditional non-Pap stains, HPV, TOTAL; Digital Imaging, CTCs, Flow Cytometry)
Table 13-7: Global Histology/Cytology Sales Distribution by Region, 2022 (%) (North America, Europe, Asia Pacific, RoW)
Table 13-8: Revenues of the Major Histology Companies, 2017-2022 ($ millions, estimated)
Table 13-9: Selected Vendors of Traditional Histology Stains
Table 13-10: Primary and Secondary Prevention of Cervical Cancer, Screening Responses by Country, 2019
Table 13-11: Selected In Situ Hybridization-based Tests
Table 13-12: Selected IHC Test Innovations
Table 13-13: Major Pharmacodiagnostic Markers
Table 13-14: Selected Pharmacodiagnostic Histology Tests
Table 13-15: Selected Digital Pathology Image Capture and Viewing Solutions
Table 11-16: FDA Digital Pathology Device Review Classification During COVID-19
Table 13-17: Selected Digital Imaging Innovations
Table 13-18: Selected Innovations in CTC Technology
Table 14-1: Abbott Diagnostics Revenue History, 2017-2021 ($ million)
Table 14-2: Abbott Diagnostic Revenues by Segment, 2017-2021 ($ million) est.
Table 14-3: Agilent Revenue History Diagnostics and Genomics, 2017-2021 ($ million)
Table 14-4: Beckman Coulter Revenue History, 2017-2021 ($ million, estimated)
Table 14-5: Beckman Coulter Diagnostic Revenues by Segment, 2017-2021 ($ million) est
Table 14-5: BD Revenue History, 2017-2021 ($ million, estimated) FYE Sept 30
Table 14-6: BD Diagnostic Revenues by Segment, 2017-2021 ($ million)
Table 14-7: bioMerieux Revenue History, 2017-2021 ($ million)
Table 14-8: bioMerieux Diagnostic Revenues by Segment, 2017-2021 ($ million)
Table 14-9: Bio-Rad Revenue History, 2017-2021 ($ million, estimated)
Table 14-10: Bio-Rad Diagnostic Revenues by Segment, 2017-2021 ($ million) est
Table 14-11: Bruker Revenue History Product revenue, 2017-2021 (all; $ million)
Table 14-12: Cepheid Revenue History, 2017-2021 ($ million, clinical product sales)
Table 14-13: Danaher Revenue History, 2017-2021 ($ million, Diagnostics, estimated)
Table 14-14: DiaSorin Revenue History, 2017-2021 ($ million)
Table 14-15: Grifols Revenue History, 2017-2021 ($ million)
Table 14-16: Grifols Diagnostic Revenues by Segment, 2017-2021 ($ million)
Table 14-17: Hologic Revenue History estimated diagnostic product revenue, 2017-2021 ($ million, estimated)
Table 14-18: Hologic Diagnostic Revenues by Segment, 2017-2021 ($ million)
Table 14-19: Recent Revenue History, 2017-2021 ($ million, estimated)
Table 14-20: IL Diagnostic Revenues by Segment, 2017-2021 ($ million)
Table 14-21: Leica Revenue History, 2017-2021 ($ millions) estimated
Table 14-22: OrthoClinical Revenue History, 2017-2021 ( in $ millions, estimated)
Table 14-23: Ortho Clinical Diagnostic Revenues by Segment ($ million) est. 2021
Table 14-24: PerkinElmer Revenue History, 2017-2021 ($ million, estimated)
Table 14-25: PerkinElmer Diagnostic Revenues by Segment, 2017-2021 ($ million) est
Table 14-26: QIAGEN Revenue History, 2017-2021 ($ million)
Table 14-27: QIAGEN Diagnostic Revenues by Segment, 2017-2021 ($ million) est
Table 14-28: Quidel Revenue History, 2017-2021 ($ million)
Table 14-29: Quidel Diagnostic Revenues by Segment, 2017-2021 ($ million) est
Table 14-30: Radiometer A/S Revenue History, 2017-2021 (estimated, $ million)
Table 14-31: Roche Revenue History, 2017-2021 (in millions $)
Table 14-32: Roche Diagnostic Revenues by Segment, 2017-2021 ($ million) est
Table 14-33: Siemens Healthineers Revenue History, 2017-2021 ($ million, estimated)
Table 14-34: Siemens Healthineers Diagnostic Revenues by Segment, 2021 ($ million)
Table 14-35: Sysmex Revenue History, , 2018-2021 ($ million) FYE March 31
Table 14-36: Sysmex Diagnostic Revenues by Segment, 2018-2021 ($ million) est
Table 14-37: Thermo Fisher Revenue History, 2017-2021 (clinical diagnostics, $ million)
Table 14-38: Thermo Fisher Scientific Diagnostic Revenues by Segment, 2017-2021 ($ million)
Table 14-39: Ventana Medical Systems Revenue History, 2017-2021 ($ millions)
Table 14-40: Werfen Recent Revenue History, 2017-2021 ($ million estimated)
Table 15-1: BGI Genomics Revenue History ($ millions)
Table 15-2: Cue Health Revenue History, 2020-2021 ($ million)
Table 15-3: Dexcom Revenue History, 2017-2021 ($ million)
Table 15-4: Eiken Chemical Revenue History FYE March 31, 2017-2021 ( $millions)
Table 15-5: Exact Sciences Revenue History, 2017-2021 (in $ millions)
Table 15-6: Fulgent Revenue History, 2017-2021 ($ million)
Table 15-7: Fujirebio Diagnostics Revenue History, 2017-2021 ($ millions) FYE March 31
Table 15-8: GenMark Revenue History, 2017-2021 ($ million)
Table 15-9: Guardant Health Revenue History, 2019-2021 ($ million)
Table 15-10: Horiba Medical Revenue History, 2017-2021 (in millions USD) (medical diagnostic sales)
Table 15-11: Illumina Revenue History, 2017-2021 ($ million - not all revenues are for clinical products and services; estimated)
Table 15-12: Illumina Diagnostic Revenues by Segment, 2017-2021 ($ million) est
Table 15-13: Labcorp Revenue History, 2017-2021 ($ millions)
Table 15-14: Luminex Revenue History, 2017-2021 ($ million; company developed tests, estimated)
Table 15-15: Masimo Revenues History, 2017-2021 ($ millions)
Table 15-16: Meridian Bioscience Revenue History, 2017-2021 ($ million, estimated) FYE Sept 30
Table 15-17: Natera Revenue History, 2017-2021 ($ millions)
Table 15-18: Myriad Genetics Revenue History, 2017-2021 ($ millions) FYE June 30
Table 15-19: Nihon Kohden Revenues History, 2017-2021 ($ millions)
Table 15-20: OraSure Technologies Revenue History, 2017-2021 ($ million)
Table 15-21: Philips Revenue History, 2017-2021 ($ millions)
Table 15-22: Quest Diagnostics Revenue History, 2017-2021 ($ million)
Table 16-1: Cerus Revenue History ($ million)
Table 16-2: Quotient Limited Revenue History, 2017-2021 ($ million)
Table 17-1: EKF Diagnostics Revenue History, 2016-2021 ($ millions)
Table 17-2: Trinity Biotech Revenue History, 2017-2021 ($ millions)
Table 18-1: Biocartis Revenue History, 2017-2021 ($ million)
Table 19-1: Insulet Corp Revenue History, 2017-2021 ($ million)
Table 19-2: Medtronic Revenue History, 2017-2021 ($ million)
Table 22-1: Biomerica Revenue History, 2017-2021 ($ million)
Table 22-2: Bio-Techne Revenue History, 2017-2021 ($ million)
Table 24-1: Accelerate Diagnostics Revenue History, 2017-2021 ($ thousands)
Table 25-1: Enzo Biochem Revenue History, 2017-2021 ($ million)
Table 25-2: Fluidigm Revenue History, 2017-2021 ($ million)
Table 25-3: NanoString Revenue History, 2017-2021 ($ million)
Table 25-4: PacBio Revenue History, 2017-2021 ($ million)
Table 26-1: Chembio Diagnostics Revenue History, 2017-2021 ($ million)
Table 26-2: genedrive Revenue History, 2017-2021 (in $ millions)
Table 26-3: MedMira Revenue History, 2017-2021 ($ thousands)
Table 29-1: Aspira Women’s Health Revenue History, 2017-2021 (in $ millions)
Table 29-2: CareDx Revenue History, 2017-2021 ($ in thousands)
Table 29-3: MDxHealth Revenue History, 2017-2021 (in $ millions)
Table 29-4: OPKO Diagnostics Revenue History, 2017-2021 (in $ millions)
Table 29-5: Veracyte Revenue History, 2017-2021 (in $ millions)
List of Figures
Figure 1-1: The Worldwide IVD Market, 2022 and 2027 ($billions)
Figure 1-1: Top Tier IVD Company Sales, 2021 vs. 2022 (percent)
Figure: 1-2: Combined Performance in COVID-19 and non-COVID-19 IVD Market Segments 2020-2027
Figure 1-3: IVD Market by Segment, 2019 Compared to 2022
Figure 2-1: Developed vs. Developing IVD Market Shares, 2022 and projected 2027 (%)
Figure 2-2: Top Tier Market Distribution, 2021 and 2022, estimated (%)
Figure 2-3: Share of IVD Market by Segment, Percentage, 2000 and 2022 Compared (Clinical Chemistry, Hematology, Coagulation, Immunoassays, Microbiology (ID/AST), POC Diabetes, POC - Other, Histology/Cytology, Molecular, Blood Banking [imm & typing], Others)
Figure 2-4: IVD Market by Segment, 2019 Compared to 2022
Figure: 2-5: Combined Performance in COVID-19 and non-COVID-19 IVD Market Segments 2020-2027
Figure 2-6: IVD COVID-19 Market, Distribution by Region (North America, Europe, Asia Pacific, RoW), 2022 (by %)
Figure 3-1: Global Fertility Rate vs. Population Size (BN). 1950-2050
Figure 3-2: Global Population Distribution, 2022
Figure 3-3: Leading Causes of Death Globally, 2019
Figure 3-4: Economic Commission Inflation Map, 2022
Figure 3-5: Eastern Europe IVD Market by Country, 2022 ($ millions) (Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Slovakia, Slovenia, Ukraine)
Figure 3-6: IVD Market Opportunity by Country: Top 20 Markets (Country Market Value ($millions), Country CAGR 2022-2027(%) (United States, Germany, Japan, France, United Kingdom, Italy, Canada, Spain, Australia, Brazil, Russia, India, Switzerland, Netherlands, Poland, Turkey, Sweden, Belgium, Mexico)
Figure 5-1: POC Glucose Testing Market Growth by Category, 2022-2027
Figure 11-1: Total COVID-19 Test Volume by Country, Average Estimates June-August 2022 (Thousands)
Figure 11-2: Estimated Market Distribution, COVID-19 Test Value, 2022

Samples

Loading
LOADING...

Companies Mentioned

  • 10x Genomics
  • 23andMe
  • AB SCIEX Pte Ltd.
  • Abbott Diagnostics
  • Abingdon Health Ltd.
  • ABX
  • Accelerate Diagnostics, Inc.
  • Advanced Biological Laboratories, S.A. (ABL)
  • Agena Bioscience, Inc.
  • Agendia BV
  • Agilent
  • altona Diagnostics
  • Ambry Genetics
  • Amoy Diagnostics Co. Ltd.
  • Angle
  • Applied Spectral Imaging Inc. (ASI)
  • ArcDia International Oy Ltd.
  • Arkray
  • ARUP Laboratories
  • Ascensia Diabetes Care Holdings AG
  • Aspira Women’s Health ( formerly Vermillion Inc.)
  • Asuragen Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company (BD)
  • Berry Genomics Co. ltd.
  • BGI Genomics (formerly Beijing Genome Institute)
  • Bigfoot Biomedical Inc.
  • Binding Site Group Ltd. (The)
  • binx Health
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Biocartis
  • Biocept, Inc.
  • Biodesix
  • BioFire Diagnostics, LLC (Acquired by bioMérieux)
  • BioGenex Laboratories, Inc.
  • Biohit Healthcare
  • Biomeme, Inc.
  • Biomerica Inc.
  • bioMérieux Inc.
  • BioReference Laboratories
  • Biotheranostics
  • Biotype Diagnostic GmbH
  • BioView Ltd.
  • BluePrint Genetics Oy
  • Boston Heart Diagnostics
  • Bruker Corporation
  • Bruker/CALID Group
  • CareDx, Inc.
  • CellaVision AB
  • Cepheid
  • Cerner Corp. (Oracle)
  • Cerus Corporation
  • Chembio Diagnostic Systems, Inc.
  • CooperGenomics (Division of CooperSurgical)
  • COPAN Diagnostics, Inc.
  • COPAN ITALIA S.p.A.
  • Corgenix Medical Corporation
  • Critical Diagnostics
  • Cue Health
  • Curetis
  • Cynvenio Biosystems (LungLife AI)
  • Dako A/S
  • Danaher Corporation
  • Debiotech SA
  • Dell Technologies Inc.
  • Dexcom Inc.
  • Diagnostica Stago, S.A.S.
  • DIAGON Kft. Hungary
  • DiaSorin Group, S.p.A.
  • Diazyme
  • DNA Electronics Ltd. (DNAe)
  • DNA Genotek
  • DxTerity Diagnostics Inc.
  • Edico Genome (Illumina)
  • Eiken Chemical Co. Ltd.
  • EKF Diagnostics Holdings PLC
  • ELITech Group S.A.S.
  • Enterome
  • Enzo Biochem Inc.
  • Epic Sciences
  • Epigenomics AG
  • ERBA Diagnostics, Inc.
  • Euformatics Oy
  • Eurobio Scientific
  • EUROIMMUN AG
  • Exact Sciences
  • Fluidigm Corporation (Standard BioTools)
  • Foundation Medicine, Inc.
  • Fujirebio Diagnostics, Inc.
  • Fulgent Genetics, Inc
  • Genedrive PLC (formerly Epistem Holdings)
  • Genetic Analysis AS
  • GeneXpert Xpress Line
  • GenMark Diagnostics, Inc
  • Genome Diagnostics BV (GenDx)
  • Genomic Health (Exact Sciences)
  • GenomOncology LLC
  • Glooko Inc.
  • Google LLC
  • Greiner Bio-One International GmbH
  • Grifols S.A.
  • Guardant Health, Inc.
  • Hain Lifescience GmbH
  • Helomics Corporation
  • HemoCue
  • Hologic, Inc.
  • Horiba Medical
  • Horizon Discovery Group PLC
  • HTG Molecular Diagnostics
  • Human Longevity Inc.
  • IBM Watson Health
  • Illumina
  • Immucor
  • Immunodiagnostic Systems (IDS)
  • Immunostics, Inc.
  • inBiome BV
  • IncellDx
  • INEX Innovate
  • INOVA Diagnostics, Inc.
  • Instrumentation Laboratory Company - A Werfen Company
  • Insulet Corporation
  • Integrity Applications Inc. (GlucoTrack)
  • Intel Corporation
  • International Business Machines Corp. (IBM)
  • Invitae
  • Labcorp, Laboratory Corporation of America
  • Leica Biosystems
  • LGC SeraCare Life Sciences, Inc.
  • LifeScan Inc.
  • Loop Medical
  • Luminex Corporation (DiaSorin)
  • Masimo Corporation
  • Mast Group
  • Mayo Clinic Laboratories
  • MDxHealth SA
  • Medica Corporation
  • MedMira, Inc.
  • MedTest DX
  • Medtronic PLC
  • Menarini Diagnostics
  • Menarini-Silicon Biosystems
  • Meridian Bioscience, Inc.
  • MGI Tech Co. Limited, China
  • MilliporeSigma
  • Mindray - Shenzhen Mindray Bio-medical Electronics Co. Ltd.
  • Mobidiag
  • Myriad Genetics, Inc.
  • NanoString Technologies, Inc.
  • Natera
  • Nemaura Medical Inc.
  • NeoGenomics
  • Nestlé Health Science
  • Nihon Kohden
  • Nova Biomedical Corporation (Nova)
  • NuGenerex Diagnostics (HDS)
  • One Lambda, Inc
  • OpGen, Inc.
  • OPKO Diagnostics
  • OraSure Technologies, Inc.
  • Ortho Clinical Diagnostics (QuidelOrtho)
  • Oxford Gene Technology
  • Pacific Biosciences of California, Inc. (PacBio)
  • PerkinElmer, Inc. (PE)
  • Philips (Royal Philips)
  • PierianDx
  • PreAnalytiX GmbH
  • Precipio, Inc. (formerly Transgenomic)
  • Q-linea AB
  • QIAGEN N.V.
  • Quanterix Corporation
  • QuantuMDx Group, Ltd.
  • Quest Diagnostics
  • Quidel Corporation (QuidelOrtho)
  • Quotient Limited
  • Radiometer A/S
  • Randox Laboratories Ltd.
  • Rennova Health, Inc.
  • Response Biomedical Corp.
  • Rheonix, Inc.
  • Roche Diagnostics
  • SD Biosensor
  • Seegene, Inc.
  • Sekisui Diagnostics LLC
  • Sequenom, Inc. (Integrated Genetics)
  • Shimadzu Scientific Instruments
  • Siemens Healthineers (Siemens)
  • Singulex, Inc.
  • Snibe Co. Ltd. (Shenzhen New Industries Biomedical Engineering Co. Ltd.)
  • Sonic Healthcare
  • SOPHiA GENETICS SA
  • Streck Inc.
  • Sysmex Corporation
  • T2 Biosystems
  • Takara Bio Inc.
  • Tecan Group
  • The Solana Business
  • Theradig
  • Thermo Fisher Scientific Inc.
  • Tosoh Bioscience
  • Trinity Biotech PLC
  • Vela Diagnostics
  • Ventana Medical Systems/Roche Tissue Diagnostics
  • Veracyte, Inc.
  • Veredus Laboratories Pte. Ltd.
  • Verily Life Sciences LLC
  • Visiopharm
  • VolitionRx Limited
  • Werfen
  • Yourgene Health